Related Experiment Video
Updated: May 20, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Reduced high-density lipoprotein antioxidant function in patients with coronary artery disease and acute coronary
Benjamin Sasko1,2, Linda Scharow3, Rhea Mueller2
1Ruhr-University of Bochum, Medical Department II, Marien Hospital Herne, Bochum, Germany.
Insights
Reduced HDL antioxidant function is linked to coronary artery disease (CAD). The nHDLox marker strongly predicts acute coronary syndrome (ACS), highlighting its role in cardiovascular pathogenesis.
Area of Science:
- Cardiovascular Science
- Biochemistry
- Clinical Medicine
Background:
- High-density lipoprotein (HDL) function, not just concentration, is crucial in coronary artery disease (CAD) pathogenesis.
- Reduced HDL antioxidant function is implicated in cardiovascular disease.
- The study investigated the association between HDL antioxidant function and stable CAD or acute coronary syndrome (ACS).
Purpose of the Study:
- To determine if reduced HDL antioxidant function is associated with stable CAD.
- To assess if reduced HDL antioxidant function is associated with acute coronary syndrome (ACS).
- To evaluate nHDLox as a predictor for ACS and CAD.
Main Methods:
- Assessed HDL antioxidant function using a cell-free biochemical assay measuring HDL-lipid peroxide content (HDLox).
- Normalized HDLox by HDL-C levels and a healthy pooled serum control to derive nHDLox.
- Analyzed nHDLox in two cohorts: elective coronary angiography patients (n=1225) and ACS patients (n=196).
Main Results:
- Participants with CAD (n=723) showed 12% higher mean nHDLox levels than those without CAD (n=502; P < 0.001).
- Patients with ACS exhibited the highest nHDLox values compared to the elective cohort (median 1.35, IQR 0.97-1.85; P < 0.001).
- Multivariate analysis confirmed nHDLox as a strong independent predictor of ACS (P < 0.001) but not of CAD (P > 0.05).
Conclusions:
- HDL antioxidant function is diminished in patients with CAD.
- The nHDLox marker is strongly associated with acute coronary syndrome (ACS).
- nHDLox may serve as a valuable biomarker for identifying patients at risk of ACS.
Results:
Participants with CAD (n = 723) had 12% higher mean relative levels of nHDLox compared with those with invasively excluded CAD (n = 502, P < 0.001). Patients presenting with symptoms of an ACS had the highest nHDLox values when compared with the elective cohort (median 1.35, IQR 0.97 to 1.85, P < 0.001). In multivariate analysis adjusted for age, sex, body mass index, and hypertension, nHDLox was a strong independent predictor of ACS (P < 0.001) but not of CAD (P > 0.05).
Conclusion:
HDL antioxidant function is reduced in patients with CAD. nHDLox is strongly associated with ACS.
Trial Registration:
German Clinical Trials Register DRKS00014037.
Funding:
Brandenburg Medical School Theodor Fontane, the BIOX Stiftung, and NIH grants R01AG059501 and R03AG059462.
Background:
High-density lipoprotein (HDL) function rather than its concentration plays an important role in the pathogenesis of coronary artery disease (CAD). The aim of the present study was to determine whether reduced antioxidant function of HDL is associated with the presence of a stable CAD or acute coronary syndrome (ACS).
Methods:
HDL function was measured in 2 cohorts: 1225 patients admitted electively for coronary angiography and 196 patients with ACS. A validated cell-free biochemical assay was used to determine reduced HDL antioxidant function, as assessed by increased HDL-lipid peroxide content (HDLox), which was normalized by HDL-C levels and the mean value of a pooled serum control from healthy participants (nHDLox; unitless). Results are expressed as median with interquartile range (IQR).
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Inflammation
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

